Brief: Infinity Pharmaceuticals Q1 Loss Per Share $0.24

Infinity Pharmaceuticals

07/05/2019 22:09

May 7 (Reuters) - Infinity Pharmaceuticals Inc  INFI.O :
    * Q1 LOSS PER SHARE $0.24
    * Q1 EARNINGS PER SHARE ESTIMATE $-0.05 -- REFINITIV IBES
DATA
    * Q1 REVENUE $2.1 MILLION
    * Q1 REVENUE ESTIMATE $6.7 MILLION -- REFINITIV IBES DATA
    * INFINITY PHARMACEUTICALS - AT MARCH 31,TOTAL CASH, CASH
EQUIVALENTS & AVAILABLE-FOR-SALE SECURITIES OF $70.5 MILLION,
COMPARED TO $58.6 MILLION AT DEC 31, 2018
    * EXPECTS NET LOSS FOR 2019 TO RANGE FROM $40 MILLION TO $50
MILLION INCLUDING COPIKTRA ROYALTY MONETIZATION
    * INFINITY PHARMACEUTICALS - EXPECTS TO END 2019 WITH
YEAR-END
CASH, CASH EQUIVALENTS & AVAILABLE-FOR-SALE SECURITIES BALANCE
RANGING FROM $40 MILLION-$50 MILLION
    * INFINITY - EXPECTS EXISTING CASH, CASH EQUIVALENTS &
AVAILABLE-FOR-SALE SECURITIES TO BE ADEQUATE TO SATISFY CO'S
CAPITAL NEEDS INTO 2H 2020

Source text for Eikon:  ID:nPnb725r0a 
Further company coverage:  INFI.O 

 ((Reuters.Briefs@thomsonreuters.com;))